These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34168449)

  • 21. Erratum: Cytotoxic and Antimicrobial Efficacy of Silver Nanoparticles Synthesized Using a Traditional Phytoproduct, Asafoetida Gum [Corrigendum].
    Int J Nanomedicine; 2020; 15():4957-4958. PubMed ID: 32764928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erratum: Doxorubicin-Loaded Poly (Lactic-Co-Glycolic Acid) Nanoparticles Coated with Chitosan/Alginate by Layer by Layer Technology for Antitumor Applications [Corrigendum].
    Int J Nanomedicine; 2021; 16():4187. PubMed ID: 34177263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erratum: Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum].
    Int J Nanomedicine; 2021; 16():7859-7860. PubMed ID: 34880611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erratum: Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum].
    Int J Nanomedicine; 2021; 16():1927. PubMed ID: 33707947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erratum: Anti-Inflammatory Effects of Magnetically Targeted Mesenchymal Stem Cells on Laser-Induced Skin Injuries in Rats [Corrigendum].
    Int J Nanomedicine; 2020; 15():6735-6736. PubMed ID: 33061356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erratum: Phase-Shift, Targeted Nanoparticles for Ultrasound Molecular Imaging by Low Intensity Focused Ultrasound Irradiation [Corrigendum].
    Int J Nanomedicine; 2020; 15():6325. PubMed ID: 32943864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erratum: Folate Decorated Multifunctional Biodegradable Nanoparticles for Gastric Carcinoma Active Targeting Theranostics [Corrigendum].
    Int J Nanomedicine; 2022; 17():3097-3098. PubMed ID: 35874113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erratum: Novel Aptamer-Functionalized Nanoparticles Enhances Bone Defect Repair by Improving Stem Cell Recruitment [Corrigendum].
    Int J Nanomedicine; 2020; 15():6093-6094. PubMed ID: 32982214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erratum: VCAM-1-Targeted Core/Shell Nanoparticles for Selective Adhesion and Delivery to Endothelial Cells with Lipopolysaccharide-Induced Inflammation under Shear Flow and Cellular Magnetic Resonance Imaging in vitro [Corrigendum].
    Int J Nanomedicine; 2022; 17():3401-3402. PubMed ID: 35942071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erratum: Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process [Corrigendum].
    Int J Nanomedicine; 2019; 14():6733-6734. PubMed ID: 31507317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erratum: Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy [Corrigendum].
    Int J Nanomedicine; 2019; 14():6867. PubMed ID: 31509111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erratum: Construction and in vivo/in vitro Evaluation of a Nanoporous Ion-Responsive Targeted Drug Delivery System for Recombinant Human Interferon α-2b Delivery [Corrigendum].
    Int J Nanomedicine; 2021; 16():4191-4192. PubMed ID: 34168451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erratum: Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells [Corrigendum].
    Int J Nanomedicine; 2023; 18():659-662. PubMed ID: 36798533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erratum: Silver Nanoparticles as Chlorhexidine and Metronidazole Drug Delivery Platforms: Their Potential Use in Treating Periodontitis [Corrigendum].
    Int J Nanomedicine; 2023; 18():1613-1614. PubMed ID: 37020687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erratum: Emodin-Conjugated PEGylation of Fe
    Int J Nanomedicine; 2022; 17():711-712. PubMed ID: 35210770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erratum: Tat-Functionalized Liposomes for the Treatment of Meningitis: An in vitro Study [Corrigendum].
    Int J Nanomedicine; 2020; 15():9317. PubMed ID: 33268985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erratum: Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum].
    Int J Nanomedicine; 2022; 17():5047-5048. PubMed ID: 36303805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erratum: Gold Nanoparticles Reduce Food Sensation in
    Int J Nanomedicine; 2023; 18():2797-2798. PubMed ID: 37250474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erratum: Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis [Corrigendum].
    Int J Nanomedicine; 2023; 18():4985-4986. PubMed ID: 37693884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erratum: A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum].
    Int J Nanomedicine; 2020; 15():6067. PubMed ID: 32884262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.